Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00281) | |||||
---|---|---|---|---|---|
Name |
Flucytosine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
5-Fluorocytosine; flucytosine; 2022-85-7; Ancobon; Ancotil; 5-Fluorocystosine; Flucytosin; Fluocytosine; 5-Fluorocytosin; Fluorcytosine; Alcobon; 4-Amino-5-fluoropyrimidin-2(1H)-one; Ro 2-9915; Flucytosinum; 4-Amino-5-fluoro-2(1H)-pyrimidinone; Cytosine, 5-fluoro-; 2(1H)-Pyrimidinone, 4-amino-5-fluoro-; 5-Flurocytosine; 5-Flucytosine; 2-Hydroxy-4-amino-5-fluoropyrimidine; Ancobon (TN); 6-amino-5-fluoro-1H-pyrimidin-2-one; Ro 29915 E/265601; NSC 103805; Flucytosine (Ancobon); 4-Amino-5-fluoro-2-hydroxypyrimidine; 117969-88-7; MFCD00006035; CHEBI:5100; UNII-D83282DT06; 4-amino-5-fluoropyrimidin-2-ol; Flucytosine (5-FC); 2-Pyrimidinol, 4-amino-5-fluoro- (9CI); MLS000069463; Flucitosina; 4-AMINO-2-HYDROXY-5-FLUOROPYRIMIDINE; 5-fluoro cytosine; NSC103805; Ro-29915; D83282DT06; NSC-103805; 130256-61-0; 4-Amino-5-fluoro-1H-pyrimidin-2-one; NCGC00016599-01; 5-FLUORO-4-IMINO-1,2,3,4-TETRAHYDROPYRIMIDIN-2-ONE; Flucitosina [DCIT]; SMR000059047; ST028644; 6-amino-5-fluoro-3-hydropyrimidin-2-one; CAS-2022-85-7; DSSTox_CID_3059; 5-Fluorocytosine, 99+%; DSSTox_RID_76856; DSSTox_GSID_23059; Flucytosinum [INN-Latin]; Flucytosone; Ancotyl; HSDB 3082; 6-Amino-2-oxo-5-fluoropyrimidine; EINECS 217-968-7; Ro-2-9915; flucytosina; Flourocytosine; Ancoban; 2(1H)-Pyrimidinone, 4-amino-5-fluoro-); 5-fluorocytocine; Flucytosine,(S); 5 Fluoro Cytosine; 4-Amino-5-fluoro-2-hyroxypyrimidine; zlchem 343; Flucytosine [USAN); Flucytosine [USAN:USP:INN:BAN:JAN]; CPD000059047; ACMC-209zxs; Opera_ID_178; 5-fluorocytosine Form I; Prestwick0_000934; Prestwick1_000934; Prestwick2_000934; Prestwick3_000934; 5-fluorocytosine Form II; EC 217-968-7; WLN: T6MVNJ DZ EF; CHEMBL1463; SCHEMBL24063; BSPBio_000868; MLS000759519; MLS001076503; MLS001424013; Flucytosine, 5-Fluorocytosine; SPBio_003037; BPBio1_000956; Flucytosine (JP17/USP/INN); DTXSID3023059; SCHEMBL14696800; 4-Amino-5-fluoro-2-pyrimidinol; ALA-ALA-PHEP-NITROANILIDE; QCR-271; ZLC0185; 2-pyrimidinol,4-amino-5-fluoro-; 4-amino-5-fluoro-pyrimidin-2-ol; HMS1570L10; HMS2051M04; HMS2093J05; HMS2097L10; HMS2233I14; HMS3373L05; HMS3393M04; HMS3655G17; HMS3714L10; Pharmakon1600-01505429; ZINC896546; 5-Fluorocytosine, nucleoside analog; BCP02877; Flucytosine 2.0 mg/ml in Methanol; HY-B0139; Tox21_110515; ANW-50846; BDBM50248003; MFCD00179326; MFCD03547958; NSC759130; SBB000061; STK292386; AKOS004912683; AKOS005063821; AKOS015896898; AKOS030241326; Tox21_110515_1; BCP9000692; CCG-100837; CCG-213434; CS-1935; DB01099; GS-5578; KS-1060; LS40595; MCULE-7094058995; NC00087; NSC-759130; Cytosine, 5-fluoro- (6CI,7CI,8CI); NCGC00016599-02; NCGC00016599-04; NCGC00016599-05; AC-11748; AK-33991; BP-30254; BR-33991; NCI60_000093; SY004438; BCP0726000281; AB0005647; AB0071040; DB-005380; 4-AMINO-5-FLUORO-2(1H)-PYRIMIDINE; AB00513969; AM20090149; FT-0601273; FT-0695664; SW197278-3; 6-amino-5-fluoro-1,2-dihydropyrimidin-2-one; 22P857; B-7734; D00323; F-3010; 16469-EP2281563A1; 16469-EP2316459A1; AB00444223-16; AB00513969-02; AB00513969_03; AB00513969_04; Flucytosine 100 microg/mL in Acetonitrile:Water; 5-Fluorocytosine, Vetec(TM) reagent grade, 99%; Q238490; SR-01000721885; Flucytosine; 6-Amino-5-fluoropyrimidin-2(1H)-one; SR-01000721885-5; BRD-K82143716-001-15-7; 5-Fluorocytosine, Antibiotic for Culture Media Use Only; Flucytosine, European Pharmacopoeia (EP) Reference Standard; Flucytosine, United States Pharmacopeia (USP) Reference Standard; Flucytosine, Pharmaceutical Secondary Standard; Certified Reference Material
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Cryptococcosis | ICD-11: 1F27 | [1] | ||
PubChem CID | |||||
Formula |
C4H4FN3O
|
||||
Canonical SMILES |
C1=NC(=O)NC(=C1F)N
|
||||
InChI |
1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9)
|
||||
InChIKey |
XRECTZIEBJDKEO-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3366"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 129.09 | Topological Polar Surface Area | 67.5 | |
XlogP | -0.9 | Complexity | 208 | ||
Heavy Atom Count | 9 | Rotatable Bond Count | 0 | ||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Flucytosine 250 mg capsule | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Sodium hydroxide; Talc; Titanium dioxide; Water; Povidone; Silicon dioxide; Gelatin; Shellac; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Lupin Pharmaceuticals; Novel Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Lactose; Butylparaben; D&c yellow no. 10; Fd&c blue no. 1; Fd&c yellow no. 6; Propylparaben; Sodium propionate; Ferrosoferric oxide; Talc; Titanium dioxide; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Oceanside Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [6] | |||
Butylparaben | DIG Info | Estrogen receptor alpha (IC50 = 1420 nM) | [7] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [2] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c yellow no. 6; Magnesium stearate; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Fd&c green no. 3; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c yellow no. 6; Ferrosoferric oxide; Talc; Titanium dioxide; Fd&c green no. 3; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Avera McKennan Hospital; Rising Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c yellow no. 6; Ferrosoferric oxide; Talc; Titanium dioxide; Fd&c green no. 3; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose, unspecified form; D&c yellow no. 10; Fd&c blue no. 1; Fd&c yellow no. 6; Ferrosoferric oxide; Talc; Titanium dioxide; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Cameron Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose, unspecified form; D&c yellow no. 10; Fd&c blue no. 1; Fd&c yellow no. 6; Talc; Titanium dioxide; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Valeant Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Flucytosine 500 mg capsule | Click to Show/Hide the Full List of Formulation(s): 6 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c red no. 40; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Sodium hydroxide; Talc; Titanium dioxide; Water; Povidone; Silicon dioxide; Gelatin; Shellac; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Lupin Pharmaceuticals; Novel Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Magnesium stearate; Ferrosoferric oxide; Titanium dioxide; Silicon dioxide; Fd&c green no. 3; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | West-Ward Pharmaceticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Lactose; Butylparaben; Propylparaben; Sodium propionate; Ferrosoferric oxide; Talc; Titanium dioxide; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Oceanside Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [6] | |||
Butylparaben | DIG Info | Estrogen receptor alpha (IC50 = 1420 nM) | [7] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [2] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium lauryl sulfate; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Carboxymethylcellulose; Gelatin; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Rising Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose, unspecified form; Ferrosoferric oxide; Talc; Titanium dioxide; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Cameron Pharmaceuticals | |||||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose, unspecified form; Ferrosoferric oxide; Talc; Titanium dioxide; Gelatin, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Valeant Pharmaceuticals | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.